XXII 22nd Century Group Inc.

1.96
-0.02  -1%
Previous Close 1.98
Open 2
Price To Book 3.5
Market Cap 244,333,600
Shares 124,660,000
Volume 536,171
Short Ratio 15.7
Av. Daily Volume 1,177,947

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Latest News

  1. CDC Survey Finds Most U.S. Adults, including 80% of Smokers, Favor Lowering Nicotine Levels in Cigarettes to Make Them Less Addictive
  2. Can We See Significant Insider Ownership On The 22nd Century Group, Inc. (NYSEMKT:XXII) Share Register?
  3. 22nd Century Group Appoints Michael J. Zercher as Chief Operating Officer
  4. Edited Transcript of XXII earnings conference call or presentation 8-May-19 8:00pm GMT
  5. 3 Marijuana Stocks to Avoid Like the Plague in May
  6. 22nd Century: 1Q Earnings Snapshot
  7. 22nd Century Files 2019 First Quarter Report and Announces Conference Call to Provide Business Update
  8. 7 Marijuana Stocks That Are Bleeding Cash
  9. 5 Best Pot Stocks in April -- Are They Buys Now?
  10. 22nd Century Group Announces FDA Inspection For Its Pre-Market Tobacco Application
  11. 22nd Century’s Pre-Market Tobacco Application for VLN™ Cigarettes Advances with Completed FDA Inspection
  12. Investors Who Bought 22nd Century Group (NYSEMKT:XXII) Shares Three Years Ago Are Now Up 120%
  13. Grossly Misleading “Short and Distort” Article Wrongfully Attempts to Dupe 22nd Century Group Shareholders
  14. 22nd Century Group Hires Former Imperial Brands Head of Regulatory Science
  15. Cannabis Stocks to Watch
  16. 22nd Century Announces Exclusive Worldwide Agreement with KeyGene for Genetic Development of Hemp/Cannabis
  17. These 5 Pot Stocks Lost at Least 15% in the First Quarter
  18. These Worst-Performing Pot Stocks Fell at Least 20% in March
  19. 22nd Century Group Issues Annual Letter to Shareholders
  20. 22nd Century’s New Study Confirms Very Low Nicotine Content Cigarettes Result in 97% Less Nicotine in Smoker’s Bloodstream